Stockscreener 앱 받기
343.53
0.85%
-2.7517
전일 마감가:
$346.28
열려 있는:
$347.01
하루 거래량:
695.69K
Relative Volume:
0.32
시가총액:
$77.40B
수익:
$194.82B
순이익/손실:
$5.53B
주가수익비율:
14.05
EPS:
24.4514
순현금흐름:
$5.34B
1주 성능:
-1.56%
1개월 성능:
+5.20%
6개월 성능:
-19.93%
1년 성능:
-18.06%
1일 변동 폭
$340.04
$349.02
1주일 범위
$335.10
$355.79
52주 변동 폭
$273.71
$458.73
엘리번스 헬스 Stock (ELV) Company Profile
명칭
Elevance Health Inc
전화
(800) 331-1476
주소
220 VIRGINIA AVENUE, INDIANAPOLIS
ELV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
343.71 | 76.96B | 194.82B | 5.53B | 5.34B | 24.45 |
|
UNH
Unitedhealth Group Inc
|
364.24 | 326.45B | 422.82B | 22.09B | 25.27B | 23.09 |
|
CVS
Cvs Health Corp
|
82.08 | 102.82B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
CI
Cigna Group
|
302.46 | 81.43B | 261.22B | 5.40B | 3.94B | 18.31 |
|
HUM
Humana Inc
|
288.51 | 35.04B | 123.11B | 1.58B | 2.44B | 13.03 |
엘리번스 헬스 Stock (ELV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-14 | 개시 | Goldman | Neutral |
| 2025-07-21 | 다운그레이드 | Argus | Buy → Hold |
| 2025-07-18 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | 업그레이드 | Argus | Hold → Buy |
| 2025-01-22 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-07-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-06-24 | 개시 | Morgan Stanley | Overweight |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2023-07-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-28 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
모두보기
엘리번스 헬스 주식(ELV)의 최신 뉴스
Elevance to penalize facilities for out-of-network providers - Modern Healthcare
Bernstein Adjusts Elevance Health Price Target to $412 From $420 - MarketScreener
Elevance Health Inc: A Key Exit in Eaton Vance Worldwide Health Sciences Fund's Q3 2025 Portfolio - Yahoo Finance
Trend analysis for Elevance Health Inc. this weekJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Is Elevance Health Inc. stock trading at a premium valuation2025 Market Trends & Expert Curated Trade Ideas - newser.com
Has Elevance Health Inc. formed a bullish divergenceQuarterly Market Summary & Consistent Growth Stock Picks - newser.com
Elevance Health: Q3 Figures Underscore Slow But Steady Recovery (NYSE:ELV) - Seeking Alpha
How Elevance Health Inc. stock reacts to Fed rate cutsJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com
What momentum indicators show for Elevance Health Inc. stock - newser.com
Why Elevance Health Inc. (A58) stock attracts wealthy investorsGlobal Markets & High Accuracy Buy Signal Tips - newser.com
Will Elevance Health Inc. stock outperform global peersJuly 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - newser.com
Elevance Health Stock To Rally 10%? Analyst Sees Upside After Q3 Print, Retail Bulls Feel It’s ‘Time To Buy’ - Stocktwits
Wells Fargo Reaffirms Their Buy Rating on Elevance Health (ELV) - The Globe and Mail
Centene And Oscar Health Stocks Sink After Molina Warning - Benzinga
TD Cowen Raises Price Target for Elevance Health (ELV) to $380 | - GuruFocus
TD Cowen Adjusts Price Target on Elevance Health to $380 From $330, Maintains Buy Rating - MarketScreener
Molina tumbles on profit forecast cut, drags broader health insurance stocks - Reuters
Elevance Health (ELV) Gets a Buy from Truist Financial - The Globe and Mail
How Elevance Health Inc. (A58) stock correlates with oil marketsLong Setup & AI Enhanced Market Trend Forecasts - newser.com
Is Elevance Health Inc. stock supported by strong cash flowsJuly 2025 News Drivers & AI Powered Market Entry Ideas - newser.com
Elevance Health (ELV) Announces Fiscal Q3 2025 Results - Insider Monkey
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members - Social News XYZ
Barclays Maintains Elevance Health (ELV) Overweight Recommendation - Nasdaq
Elevance Health Named Top Dividend Stock With Insider Buying and 1.96% Yield (ELV) - Nasdaq
Elevance CFO: 2026 Should Mark ‘The Trough’ For Medicaid Margins - HCI Innovation Group
Leerink Partners Adjusts Price Target on Elevance Health to $350 From $310, Maintains Market Perform Rating - MarketScreener
Goldman Sachs Adjusts Price Target on Elevance Health to $331 From $343, Maintains Neutral Rating - MarketScreener
Barclays Adjusts Price Target on Elevance Health to $385 From $395, Maintains Overweight Rating - MarketScreener
Barclays Lowers Price Target for Elevance Health (ELV) to $385 | ELV Stock News - GuruFocus
Elevance: Checking Out The Q3 Test Results (NYSE:ELV) - Seeking Alpha
Historical volatility pattern of Elevance Health Inc. visualized2025 Macro Impact & Low Risk Entry Point Tips - newser.com
Elevance Health Reports Strong Q3 2025 Revenue Growth - TipRanks
Elevance Health Inc (ELV): A Strategic SWOT Insight - GuruFocus
Elevance Health: Q3 Earnings Snapshot - Stamford Advocate
Visual trend scoring systems applied to Elevance Health Inc.July 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Elevance Health Inc (ELV) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Medicaid ... By GuruFocus - Investing.com Canada
Elevance Health execs expect Medicaid costs to rise in 2026 - Fierce Healthcare
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Elevance Health Inc (ELV) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Medicaid ... - Yahoo Finance
Why Is Elevance Health Stock Falling Tuesday?Elevance Health (NYSE:ELV) - Benzinga
Elevance health unfazed by 'elevated' commercial group medical costs - BenefitsPRO
Elevance Health Q3 Earnings Beat Estimates on Strong MA Membership - Zacks Investment Research
Elevance Health Inc (ELV) Q3 2025 Earnings Call Highlights: Stro - GuruFocus
Elevance Health, Inc. Declares Fourth Quarter Dividend, Payable on December 19, 2025 - MarketScreener
What’s next for Elevance Health Inc. stock priceMarket Growth Review & Safe Swing Trade Setups - newser.com
Elevance flags higher costs in Medicaid business in 2026, shares retreat - Reuters
Elevance Health (ELV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - sharewise.com
Why Elevance Health (ELV) Shares Are Falling Today - Yahoo Finance
Elevance Health, Inc. SEC 10-Q Report - TradingView
Elevance Health Q3 2025 slides: Revenue surges 12% while margins contract - Investing.com
Elevance Health warns of sustained Medicaid pressures - Modern Healthcare
엘리번스 헬스 (ELV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
1.25%
자본화:
|
볼륨(24시간):